|
Dr. Rui Avelar is Angiotech's Chief Medical Officer and is responsible for medical market analysis, product concept, development and clinical trial design. Dr. Avelar brings to the company over a decade of clinical experience from his previous medical practice where he specialized in Sports Medicine. He also brings knowledge of the pharmaceutical industry and markets from a previously held position as a healthcare analyst for a Canadian securities firm prior to joining Angiotech. Dr. Avelar remains active in the medical community by currently serving as the team physician for the NHL franchise team, The Vancouver Canucks.
Dr. Avelar received his medical degree from the University of Toronto in 1989 and went on to further training and accreditation in Sports Medicine receiving his certification from the Canadian Academy of Sports Medicine. | 